RxAnte

Portland, ME · Founded 2011 · Acquired/Merged (Operating Subsidiary)

Provider of predictive analytics and targeted clinical programs intended to improve medication prescribing and adherence. RxAnte is based in Portland, ME and was founded in 2011. Its last known valuation is $28.9 million (Nov 2020). It has raised $49.8 million across 1 recorded round; the latest was a $10.9 million debt round in Oct 2020.

Last price · $/share
—
Implied valuation
$28.9M
Total raised
$49.8M
Last round
Debt
Oct 2020
How much has RxAnte raised?
$49.8Macross 1 recorded rounds · Oct 2020 – Oct 2020

Most recently, RxAnte raised $10.9M in its Debt (Oct 2020).

Free account
More of RxAnte with a free account
  • ·Watch RxAnte: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

RxAnte round by round

1 rounds
Oct 2020Debt$10.9MSEC filing▮
7 investors participated

How much has RxAnte raised?

RxAnte has raised $49.8 million in total; 1 of its rounds is on record. The largest on record was a $10.9 million debt round in Oct 2020.

RxAnte has filed 2 Form Ds with the SEC since 2020, most recently in May 2022 ($10.9 million sold to 7 investors).

RxAnte investors

4 investors are on record for RxAnte, including First Trust Capital Partners, PNC Erieview Capital, Primus Capital and Trinity Capital (Phoenix). The debt round in Oct 2020 drew 7 investors.

For fundraisers
Raising for a company like RxAnte?

4 investors have backed RxAnte.

See all 4 investors →

Frequently asked about RxAnte

How much has RxAnte raised?
RxAnte has raised $49.8M in total across 1 recorded funding rounds.
When was RxAnte's last funding round?
RxAnte's most recent recorded round was Debt in Oct 2020, raising $10.9M.